Does anyone know if this has been reported before?Patient Case Study: Four Cycles of 4GBq of67Cu-SAR-bisPSMA
A patient from cohort 1 of the SECuRE trial whoreceived a total of four cycles of 4GBq of67Cu-SAR-bisPSMA (one dose from theSECuRE trial and three from the EAP) exhibiteda considerable reduction in the intensity of thetherapeutic 67Cu-SAR-bisPSMA product uptakeat the lesion sites. A reduction of greater than90% in PSA was observed after the fourth cycleof 4GBq of 67Cu-SAR-bisPSMA.
Its been said before, but the quality of communication from CU6 is excellent. And all the signals of efficacy in the dose escalation phase of its trials - very exciting.
- Forums
- ASX - By Stock
- Ann: Half Yearly Report and Accounts
Does anyone know if this has been reported before?Patient Case...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CU6 (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.65 |
Change
0.380(11.6%) |
Mkt cap ! $1.134B |
Open | High | Low | Value | Volume |
$3.30 | $3.75 | $3.29 | $15.67M | 4.533M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 6405 | $3.60 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.65 | 13893 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 6405 | 3.600 |
1 | 1000 | 3.550 |
1 | 2824 | 3.540 |
1 | 1500 | 3.510 |
2 | 1821 | 3.500 |
Price($) | Vol. | No. |
---|---|---|
3.650 | 13893 | 3 |
3.660 | 28396 | 1 |
3.670 | 1089 | 1 |
3.680 | 10000 | 1 |
3.690 | 5515 | 3 |
Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
Last
$3.65 |
  |
Change
0.380 ( 11.9 %) |
|||
Open | High | Low | Volume | ||
$3.29 | $3.76 | $3.29 | 345059 | ||
Last updated 15.59pm 03/05/2024 ? |
Featured News
CU6 (ASX) Chart |